Molecular Pathology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eastick, K
Right arrow Articles by Millar, M R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eastick, K
Right arrow Articles by Millar, M R
Molecular Pathology 2003;56:25-28
© 2003 BMJ Publishing Group & Association of Clinical Pathologists


ORIGINAL ARTICLE

A novel polymerase chain reaction assay to detect Mycoplasma genitalium

K Eastick1, J P Leeming1, E O Caul2, P J Horner3 and M R Millar1

1 Public Health Laboratory, Level 8, Bristol Royal Infirmary, Maudlin Street, Bristol BS2 8HW, UK
2 Public Health Laboratory, Myrtle Road, Kingsdown, Bristol BS2 8EL, UK
3 The Milne Centre for Sexual Health, Bristol Royal Infirmary, Maudlin Street, Bristol BS2 8HW, UK

Correspondence to:
Dr K Eastick, Royal Infirmary of Edinburgh, Regional Clinical Virology Laboratory, Little France, Old Dalkeith Road, Edinburgh, EH16 4SU, UK
eastick{at}btinternet.com

Aims: To design and validate a polymerase chain reaction (PCR) assay targeting the 16S rRNA gene of Mycoplasma genitalium.

Methods: Primers were designed that were complementary to the 16S rRNA gene sequence of M genitalium. After optimisation of the reaction conditions, the PCR was tested against nine M genitalium strains, a dilution series of M genitalium DNA, and a panel of common microorganisms. The PCR was also challenged in parallel with a published assay against 54 urine specimens from men with urethritis.

Results: The expected 341 bp product was produced on amplification of material from all M genitalium strains and from none of the other microorganisms tested. The lower limit of detection was 50 genome copies. The new assay detected M genitalium DNA in nine of 54 men with urethritis, in comparison with eight positive specimens detected with the alternative PCR.

Conclusions: This novel PCR targeting the M genitalium 16S rRNA gene has been optimised and now provides a sensitive and specific alternative or addition to the available MgPa gene targeting assays.


Keywords: Mycoplasma genitalium; polymerase chain reaction; urethritis

Abbreviations: HPF, high power field; IDEIA, amplified enzyme immunoassay; NGU, non-gonococcal urethritis; PCR, polymerase chain reaction; PMNL, polymorphonuclear leucocyte




This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
J. Hardick, J. Giles, A. Hardick, Y.-H. Hsieh, T. Quinn, and C. Gaydos
Performance of the Gen-Probe Transmission-Mediated Amplification Research Assay Compared to That of a Multitarget Real-Time PCR for Mycoplasma genitalium Detection
J. Clin. Microbiol., April 1, 2006; 44(4): 1236 - 1240.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Molecular Pathology Journal of Clinical Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.